Kuang-Chi is a world-class Shenzhen-based disruptive technology group, with operations across the globe from China to North America, Europe, Africa and Oceania. In January 2017, Kuang-Chi was making its first UK investment announcement of $30million in Gilo Industries Ltd, a Dorset based advanced aerospace technology company.
The objectives were three-fold; to generate buzz, excitement and profile for Kuang-Chi around the signing of the deal in UK with the international media and key stakeholders, to assist with administration and logistics around an event and to secure attendance of important journalists and other VIP guests.
PRO advised on the event location, format and logistics for the event. The Royal Institute of Chartered Surveyors was chosen for its prestige as well as its proximity to Westminster. The team collated the invitee list including MPs, peers and individuals from the technology sector and was responsible for issuing invites, securing attendance and drafting all content including the invitation and presentations. The PR Office also arranged speakers from China-Britain Business Council and the Department for International Trade.
As well as inviting the media to the event, PRO advised on the wider media engagement strategy, securing an exclusive with the FT on the day of the launch as well as a number of broadcast interviews. The transaction was then announced in a press release to be issued on the day of the event. We recommended keeping the announcement confidential from the time of signing until the morning of the event so as to maximise media interest and potential impact. At the event, we arranged further media interviews, with invited media, and worked with a cameraman and photographer to produce a video and photos to be used in ongoing marketing collateral.
OurCrowd, the leading global equity crowdfunding platform is the world’s most innovative example of democratising investment for startups. With over 110 companies in its portfolio, and over 17,000 accredited investors on the platform, OurCrowd is pioneering investments in new areas including Machine Learning, Cyber, Robotics, Agtech, SportsTech, Digital Health and SpaceTech.
PRO was engaged to raise the profile of OurCrowd and achieve a significant uplift in media coverage, as well as raise the profile of its CEO, Jon Medved, and its relevant Portfolio Companies.
We provided PR and strategic guidance for OurCrowd and all its portfolio companies, raising the visibility of the brand through the creation of media content and generating news stories, as well as, capitalising on its financial announcements.
Our results include regularly achieving coverage in all major target business publications including TechCrunch, Business Insider, Forbes, Fortune, CNN, CNBC, Bloomberg and Reuters as well as sector trades specific to the portfolio companies.
MedAware was initiated following a tragic case of a nine-year-old boy who died because his primary-care physician accidentally prescribed the wrong drug. Sadly, this case is not uncommon. Prescription errors are estimated to cause the premature injury and death of more than 200,000 patients every year in the United States alone.
PRO was engaged to raise the profile of MedAware and its potentially life-saving service.
PRO worked alongside Harvard Medical School following the publishing of its landmark findings n the Journal of American Medical Informatics Association (JAMIA). The findings found that using MedAware technology, prescription errors can be reduced as much as 75% and thus 200K lives per year can be saved from death or serious harm in the US alone.
PRO worked to highlight the issues around prescription errors, raising the profile of MedAware as the solution.
The PR Office achieved 271 pieces of media coverage, including syndicated pieces for MedAware following the study published by Harvard Medical School in the Journal of American Medical Informatics Association (JAMIA) on 19 January.
PRO worked with the key medical trades, securing coverage in a number of outlets including MobiHealth News, Pharmacy Life and MedCity News.